We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
- Authors
Ben‐Aharon, Irit; Granot, Tal; Meizner, Israel; Hasky, Noa; Tobar, Ana; Rizel, Shulamith; Yerushalmi, Rinat; Ben‐Haroush, Avi; Fisch, Benjamin; Stemmer, Salomon M.
- Abstract
Background. We previously reported that chemotherapy-induced ovarian toxicity may result from acute vascular insult, demonstrated by decreased ovarian blood flow and diminished post-treatment anti-Mullerian hormone (AMH) levels. In the present study, we report the continuous prospective evaluation of ovarian function in that cohort. Methods. Patients (aged <43 years) with localized breast cancer were evaluated by transvaginal ultrasound prior to initiation of chemotherapy, immediately at treatment completion, and at 6 and 12 months after treatment cessation. Doppler flow velocity indices of the ovarian vasculature (resistance index [RI], pulsatility index [PI]) were visualized. Hormone markers of ovarian reserve were assessed at the same time points. Results. Twenty patients were enrolled in the study. Median age was 34 6 5.24 years. Ovarian blood flow was significantly reduced immediately following chemotherapy (both RI and PI; p 5 .01). These parameters were partially recovered at later points of assessment (6 and 12 months after treatment); patients aged <35 years significantly regained ovarian blood flow compared with patients aged >35 years (p < .05). AMH dropped dramatically in all patients following treatment (p < .001) and recovered in only 10 patients. Hormone markers of ovarian reserve shortly after chemotherapy depicted a postmenopausal profile for most patients, accompanied by related symptoms. Follicle-stimulating hormone (FSH) levels recovered in 14 of 20 patients and significantly returned to the premenopausal range in patients aged <35 years (p 5 .04); 10 of 20 resumed menses at 12 months. The pattern of vascular impairment was lessened in patients treated with a trastuzumab-based protocol, although results did not reach statistical significance (p 5 .068). Conclusion. Continuous prospective evaluation of ovarian vasculature and function in a cohort of young patients during and after chemotherapy indicated that ovarian toxicity may derive from acute vascular insult. Age may affect whether patients regain ovarian function, whereas recovery of blood flow and premenopausal FSH levels at later assessment was notable in patients aged <35 years.
- Subjects
DOPPLER ultrasonography; BREAST tumors; CANCER chemotherapy; DRUG toxicity; GENES; HISTOLOGY; HORMONES; OVARIAN diseases; RESEARCH funding; DATA analysis software; DESCRIPTIVE statistics; GENOTYPES
- Publication
Oncologist, 2015, Vol 20, Issue 9, p985
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1634/theoncologist.2015-0044